| A Study of MK-1167 in Healthy Elderly Participants (MK-1167-004) (NCT06625840) | Merck Sharp & Dohme LLC | 2023-09-18 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects (NCT06036784) | MBX Biosciences | 2023-09-18 |
| Safety and Viability of an E. Coli Nissle Colibactin Knockout in Healthy Volunteers (NCT05816577) | Max Nieuwdorp | 2023-09-18 |
| Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion (NCT05976646) | Virginia Commonwealth University | 2023-09-18 |
| Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients (NCT05743504) | National Taiwan University Hospital | 2023-09-18 |
| Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation (NCT06117371) | BeBetter Med Inc | 2023-09-18 |
| A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis (NCT05951816) | University of Tennessee Graduate School of Medicine | 2023-09-18 |
| Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation (NCT06001593) | Seoul National University Hospital | 2023-09-18 |
| Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults (NCT06026514) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-09-18 |
| A DDI Study of JMKX000623 and Metformin Hydrochloride (NCT06066060) | Jemincare | 2023-09-17 |
| Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA (NCT05769478) | Wake Forest University Health Sciences | 2023-09-15 |
| 3D Printed Models for Liver Surgery (NCT06006338) | Zhejiang Cancer Hospital | 2023-09-15 |
| Phase 1 Study of AWT020 in Advanced Cancer (NCT06092580) | Anwita Biosciences | 2023-09-15 |
| A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121 (NCT06025773) | Addpharma Inc. | 2023-09-15 |
| A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570 (NCT06000891) | Zealand Pharma | 2023-09-15 |
| The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus (NCT06159686) | Thammasat University Hospital | 2023-09-15 |
| Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects (NCT05997641) | Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm) | 2023-09-15 |
| A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial (NCT06026254) | ImmuneSensor Therapeutics Inc. | 2023-09-15 |
| Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer (NCT05756907) | Sonnet BioTherapeutics | 2023-09-15 |
| An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors (NCT06038461) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-09-15 |
| A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection) (NCT06048120) | Bayer | 2023-09-15 |
| A Study in Healthy People to Test How Well Repeated Doses of BI 3032950 Are Tolerated (NCT05985200) | Boehringer Ingelheim | 2023-09-15 |
| OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion. (NCT06421610) | Odense University Hospital | 2023-09-15 |
| A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants (NCT06049108) | Eli Lilly and Company | 2023-09-15 |
| Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer (NCT05401110) | Karen Reckamp, MD, MS | 2023-09-15 |
| A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001) (NCT05953740) | Merck Sharp & Dohme LLC | 2023-09-15 |
| Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss (NCT05821959) | Akouos, Inc. | 2023-09-15 |
| Bioequivalence Study of Perampanel Tablets 12 mg (NCT06450223) | Humanis Saglık Anonim Sirketi | 2023-09-14 |
| Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers. (NCT06042192) | Teikoku Seiyaku Co., Ltd. | 2023-09-14 |
| The Safety and Effectiveness of NV-A01 in Glioma Patients (NCT06193538) | First Affiliated Hospital of Wannan Medical College | 2023-09-14 |
| Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Hepatic Impairment (NCT06161259) | Guangdong Raynovent Biotech Co., Ltd | 2023-09-14 |
| ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06182072) | ProDa BioTech, LLC | 2023-09-14 |
| Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers (NCT05691504) | National Cancer Institute (NCI) | 2023-09-14 |
| Study to Evaluate Safety and Activity of TRL345 in Healthy Volunteers (NCT05408091) | Trellis Bioscience LLC | 2023-09-14 |
| IKS014 in Advanced Solid Tumors That Express HER2 (NCT05872295) | Iksuda Therapeutics Ltd. | 2023-09-14 |
| A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors (NCT06016062) | RemeGen Co., Ltd. | 2023-09-14 |
| Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia (NCT06085638) | M.D. Anderson Cancer Center | 2023-09-14 |
| A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity (NCT06049329) | Novo Nordisk A/S | 2023-09-14 |
| Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male Participants (NCT06045000) | DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company | 2023-09-14 |
| A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) (NCT05869955) | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2023-09-13 |
| A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects (NCT06019065) | AJNA Australia Pty Ltd | 2023-09-13 |
| Evaluate Tolerability and Safety of HY209 in Healthy Volunteers (NCT06533878) | Kukjeon Pharmaceutical Co.,Ltd. | 2023-09-13 |
| A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma (NCT05797805) | Iterion Therapeutics | 2023-09-13 |
| A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain (NCT05844995) | Johnson & Johnson Consumer Inc. (J&JCI) | 2023-09-13 |
| Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age (NCT05534529) | Mundipharma Research Limited | 2023-09-13 |
| Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) (NCT05882734) | EMD Serono Research & Development Institute, Inc. | 2023-09-13 |
| Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer (NCT06081686) | Sinotau Pharmaceutical Group | 2023-09-13 |
| Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia (NCT05487807) | University of Southern California | 2023-09-13 |
| Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) (NCT05377905) | Falo, Louis, MD | 2023-09-13 |
| Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies (NCT06034275) | Vincerx Pharma, Inc. | 2023-09-13 |
| A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants (NCT06033547) | ViiV Healthcare | 2023-09-12 |
| A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD) (NCT06004180) | H. Lundbeck A/S | 2023-09-12 |
| A Phase I Study of XJ103 in Chinese Healthy Subjects (NCT06026748) | Starmab biologics（Shanghai）Co,.ltd | 2023-09-12 |
| A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy (NCT06068608) | Zhuhai Trinomab Pharmaceutical Co., Ltd. | 2023-09-12 |
| Phase I/II Clinical Study of 1A46 Drug Substance (NCT05987605) | BioRay Pharmaceutical Co., Ltd. | 2023-09-12 |
| A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies (NCT05665530) | Prelude Therapeutics | 2023-09-12 |
| Sleep Health Enhancement in Older Adults to Address Frailty (NCT05968820) | University of Kansas Medical Center | 2023-09-12 |
| A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese (NCT06039826) | Eli Lilly and Company | 2023-09-12 |
| A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. (NCT06064812) | Forward Pharmaceuticals Co., Ltd. | 2023-09-12 |
| Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women (NCT05829629) | BlueSky Immunotherapies GmbH | 2023-09-12 |
| Fellow-eye Study (FE) of LX101 in Subjects With Inherited Retinal Dystrophy (NCT06212297) | Innostellar Biotherapeutics Co.,Ltd | 2023-09-12 |
| TAS-116 Plus Palbociclib in Breast and Rb-null Cancer (NCT05655598) | Brown University | 2023-09-12 |
| Effect of Food on the Pharmacokinetics of ORIC-114 (NCT06012721) | ORIC Pharmaceuticals | 2023-09-11 |
| Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 (NCT06012708) | New Cancer Cure-Bio Co.,Ltd. | 2023-09-11 |
| Phase 1 Study of 68Ga-R8760 (NCT05999292) | Radionetics Oncology | 2023-09-11 |
| First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI (NCT05920135) | Bridge Biotherapeutics, Inc. | 2023-09-11 |
| Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer (NCT05877430) | CJ Bioscience, Inc. | 2023-09-11 |
| Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals (NCT06117020) | Motric Bio | 2023-09-11 |
| A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Zongertinib in the Blood (NCT06028464) | Boehringer Ingelheim | 2023-09-11 |
| Naltrexone and Propranolol Combined With Immunotherapy (NCT05968690) | Sarah Weiss | 2023-09-11 |
| Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD (NCT06707753) | Beijing Anlong Biopharmaceutical Co., Ltd. | 2023-09-11 |
| Coordinated Reset Deep Brain Stimulation for Essential Tremor (NCT05897775) | University of Minnesota | 2023-09-11 |
| Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects. (NCT06211283) | Desitin Arzneimittel GmbH | 2023-09-11 |
| Pan-Malaria Transmission-Blocking Vaccine AnAPN1 (NCT05905432) | Centre de Recherche Médicale de Lambaréné | 2023-09-11 |
| Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia (NCT06027853) | Zhejiang University | 2023-09-10 |
| Dead Mesenchymal Stem Cells for Radiation Lung Injury (NCT06021067) | Sichuan University | 2023-09-10 |
| To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers (NCT06378684) | JW Pharmaceutical | 2023-09-10 |
| A Study on the Safety, Pharmacokinetics, and Food Effects of MI078 Capsules (NCT06982651) | Nanjing Minova Pharmaceutical Co., Ltd. | 2023-09-09 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers (NCT06034015) | Jiangsu Yahong Meditech Co., Ltd aka Asieris | 2023-09-09 |
| A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH (NCT05945537) | Inipharm Australia Pty Ltd | 2023-09-08 |
| A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma (NCT05664243) | In8bio Inc. | 2023-09-08 |
| NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration (NCT05984927) | Elisigen, Inc. | 2023-09-08 |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms (NCT06026774) | Sir Run Run Shaw Hospital | 2023-09-08 |
| A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood (NCT05934942) | Boehringer Ingelheim | 2023-09-08 |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms (NCT06019702) | Sir Run Run Shaw Hospital | 2023-09-08 |
| A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma (NCT05621668) | M.D. Anderson Cancer Center | 2023-09-08 |
| Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis (NCT05532943) | Ever Supreme Bio Technology Co., Ltd. | 2023-09-08 |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms (NCT06026800) | Sir Run Run Shaw Hospital | 2023-09-08 |
| Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs (NCT05857384) | Incannex Healthcare Ltd | 2023-09-08 |
| The First-in-human Study of SRN-001 in Healthy Participants (NCT05984992) | siRNAgen Therapeutics Inc. | 2023-09-08 |
| Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts (NCT06055777) | Suzhou Erye Pharmaceutical Co., Ltd. | 2023-09-07 |
| RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated NSCLC (NCT05821933) | RemeGen Co., Ltd. | 2023-09-07 |
| Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response (NCT05915013) | Yale University | 2023-09-07 |
| A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors (NCT05946226) | Suzhou Immunofoco Biotechnology Co., Ltd | 2023-09-07 |
| CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors (NCT06006390) | Chongqing Precision Biotech Co., Ltd | 2023-09-07 |
| OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors (NCT07382531) | Binhui Biopharmaceutical Co., Ltd. | 2023-09-07 |
| Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors (NCT06014502) | ImmunoGenesis | 2023-09-07 |
| Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants (NCT06037148) | Desentum Oy | 2023-09-07 |
| Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors (NCT06040541) | Revolution Medicines, Inc. | 2023-09-07 |
| D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients (NCT05734560) | Darell Bigner | 2023-09-06 |